Status:
UNKNOWN
Comparative Genomic Profiling of Lung Adenocarcinoma in Asians and Caucasians: A Propensity Matched Analysis
Lead Sponsor:
Jun Wang
Collaborating Sponsors:
Berry Genomics Co., Ltd.
Memorial Sloan Kettering Cancer Center
Conditions:
Adenocarcinoma of Lung
Eligibility:
All Genders
18-85 years
Brief Summary
Lung adenocarcinomas (LUADs) from Asian ancestry are reported to have different genomic architectures compared with LUADs from Caucasian ancestry. However, due to lack of available cases, few studies ...
Eligibility Criteria
Inclusion
- Primary lung adenocarcinoma
- Broad-panel next-generation sequencing
- Asian
Exclusion
- Inadequate clinicopathological information
- Low-quality next-generation sequencing
Key Trial Info
Start Date :
January 1 2021
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 1 2021
Estimated Enrollment :
450 Patients enrolled
Trial Details
Trial ID
NCT04692935
Start Date
January 1 2021
End Date
December 1 2021
Last Update
January 5 2021
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.